ClinicalTrials.govpublic full text
Evaluating Drug Interactions Between Doravirine With Estradiol and Spironolactone in Healthy Transgender Women
transgender health, gender dysphoria, transgender women, human immunodeficiency virus, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 893537
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.